May 23, 2017 / 5:21 AM / 3 months ago

BRIEF-BerGenBio Q1 net loss widens to NOK 65.1 mln

May 23 (Reuters) - BERGENBIO ASA:

* Q1 NET LOSS NOK 65.1 MILLION VERSUS LOSS NOK 20.3 MILLION YEAR AGO

* Q1 OPERATING LOSS NOK 65.8 MILLION VERSUS LOSS NOK 20.7 MILLION YEAR AGO

* THE COMPANY IS PROGRESSING FOUR PHASE II CLINICAL TRIALS WITH BGB324 TOWARDS SIGNIFICANT VALUE INFLECTION POINTS, WITH READ-OUTS EXPECTED IN 2018 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below